Table 2 Use and concomitant use of psychotropics at baseline among 1,177 participants

One BZD

76 (15.8)

187 (26.9)

<.001

One AP

31 (6.4)

64 (9.2)

.10

One AD

14 (2.9)

38 (5.5)

.04

At least two BZDs

13 (2.7)

37 (5.3)

.03

At least two APs

5 (1.0)

9 (1.3)

.79

At least two ADs

1 (0.2)

0 (0.0)

.41

BZD and AP^b

19 (3.9)

29 (4.2)

.88

BZD and AD^b

10 (2.1)

25 (3.6)

.16

AP and AD^b

5 (1.0)

13 (1.9)

.34

At least one psychotropic drug

92 (19.1)

229 (32.9)

<.001